LEADER 01788nam  2200565   450 
001 9910779717203321
005 20210713200714.0
010   $a0-87389-220-8
010   $a0-87389-221-6
010   $a600-00-4935-8
035   $a(CKB)2550000001102227
035   $a(EBL)3002620
035   $a(SSID)ssj0000887240
035   $a(PQKBManifestationID)12466003
035   $a(PQKBTitleCode)TC0000887240
035   $a(PQKBWorkID)10840939
035   $a(PQKB)11718240
035   $a(Au-PeEL)EBL3002620
035   $a(CaPaEBR)ebr10929580
035   $a(OCoLC)893681458
035   $a(MiAaPQ)EBC3002620
035   $a(EXLCZ)992550000001102227
100   $a20120120d2012      uy|            0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aDevelopment of FDA-regulated medical products $ea translational approach /$fElaine Whitmore
205   $aSecond edition.
210  1$aMilwaukee, Wisconsin :$cASQ Quality Press,$d2012.
215   $a1 online resource (255 p.)
300   $aDescription based upon print version of record.
311   $a9780873898331 
320   $aIncludes bibliographical references and index.
606   $aDrug approval$zUnited States
606   $aBiological products$xStandards$zUnited States
606   $aMedical instruments and apparatus$xStandards$zUnited States
615  0$aDrug approval
615  0$aBiological products$xStandards
615  0$aMedical instruments and apparatus$xStandards
676   $a615.1/9
700   $aWhitmore$b Elaine$01508118
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910779717203321
996   $aDevelopment of FDA-regulated medical products$93739327
997   $aUNINA